Montserrat Plana - Concepedia

Author

Montserrat Plana

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ORCID

Also Known As

A. León, Carmen Pastor, M Plana, M. Plana, Montserrat Mauri Plana, Montserrat Plana, Montserrat Plana Prades, Nuria Climent, Pilar Callau

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Universitat de Barcelona Hospital Clínic de Barcelona Instituto de Salud Carlos III IrsiCaixa

About

Montserrat Plana is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in hiv, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	522
2	Cell Biology	3	3	97
3	Engineering	1	1	28
4	Health Sciences	1	1	20
5	Allergy	1	1	11

Montserrat Plana

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy Felipe García, Montserrat Plana, Carmen Vidal, AIDS	1999	273
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection Annette Oxenius, David A. Price, Huldrych F. Günthard, Proceedings of the National Academy of Sciences	2002	213
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection Felipe García, Montserrat Plana, Gabriel M. Ortiz, AIDS	2001	194
A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection Felipe García, Núria Climent, Lambert Assoumou, The Journal of Infectious Diseases VaccinationAutologous Hiv-1Plasma Viral LoadVaccine RecipientsHuman Retrovirus	2011	132
Plasma Stromal Cell–Derived Factor (SDF)‐1 Levels, SDF1‐3′A Genotype, and Expression of CXCR4 on T Lymphocytes: Their Impact on Resistance to Human Immunodeficiency Virus Type 1 Infection and Its Progression Àlex Soriano, Catalina Martínez, Felipe García, The Journal of Infectious Diseases	2002	123
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection Montserrat Plana, Felipe García, Teresa Gallart, AIDS	2000	92
Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial Josep Ordi‐Ros, Luís Sáez-Comet, Mercedes Pérez-Conesa, Annals of the Rheumatic Diseases	2017	85
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02) Felipe García, Juan Carlos López Bernaldo de Quirós, Carmen Gómez, Vaccine VaccinationVaccine DevelopmentHealthy Hiv-1-uninfected VolunteersNef ProteinsMedicine	2011	80
The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens Carmen Gómez, José Luis Nájera, Beatriz Perdiguero, Journal of Virology T Cell ResponsesAdaptive Immune SystemImmunodeficienciesImmunologyImmunodominance	2011	75
Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection María Pernas, Laura Tarancón‐Díez, Esther Rodríguez‐Gallego, Journal of Virology	2017	74

Page 1